Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Organogenesis Holdings Inc shares valued at $413,625 were purchased by Freedman Lori on Jun 05 ’25. At $2.91 per share, Freedman Lori acquired 142,379 shares. The insider’s holdings grew to 837,437 shares worth approximately $3.77 million following the completion of this transaction.
Also, Freedman Lori purchased 100,863 shares, netting a total of over 284,716 in proceeds. Following the buying of shares at $2.82 each, the insider now holds 695,058 shares.
Before that, Freedman Lori had added 9,022 shares to its account. In a trade valued at $26,949, the Chief Admin. and Legal Officer bought Organogenesis Holdings Inc shares for $2.99 each. Upon closing the transaction, the insider’s holdings increased to 9,022 shares, worth approximately $3.81 million.
As published in their initiating research note from Lake Street on June 28, 2024, Organogenesis Holdings Inc [ORGO] has been a Buy and the price target has been revised to $5. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early February. As of June 15, 2023, Morgan Stanley has initiated its “an Equal-weight” rating for ORGO. Earlier on May 24, 2023, BTIG Research upgraded its rating. Their new recommendation was “a Buy” for ORGO stock which previously was a “a Neutral”.
Analyzing ORGO Stock Performance
On last trading session, Organogenesis Holdings Inc [NASDAQ: ORGO] plunged -0.66% to $4.5. The stock’s lowest price that day was $4.4709, but it reached a high of $4.585 in the same session. During the last five days, there has been a drop of approximately -3.43%. Over the course of the year, Organogenesis Holdings Inc shares have jumped approximately 69.17%.
Is Organogenesis Holdings Inc subject to short interest?
Stocks of Organogenesis Holdings Inc saw a sharp steep in short interest on 2025-07-15 dropping by -1.08 million shares to 9.73 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 10.81 million shares. A decline of -11.05% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.44 of the overall float, the days-to-cover ratio (short ratio) decline to 9.44.
Which companies own the most shares of Organogenesis Holdings Inc (ORGO)?
In terms of Organogenesis Holdings Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 32.45% from the previous closing price of $4.53. Analysts anticipate Organogenesis Holdings Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 3 analysts ranked Organogenesis Holdings Inc stock as Buy at the end of 2025.
